Skip Nav Destination
1-20 of 28
Keywords: Esophageal squamous cell carcinomaClose
Junya Kitadani, Toshiyasu Ojima, Keiji Hayata, Taro Goda, Akihiro Takeuchi, Shinta Tominaga, Naoki Fukuda, Tomoki Nakai, Hiroki Yamaue, Manabu Kawai
Published Online: 14 September 2023
...-fluorouracil (DCF) therapy for resectable advanced esophageal squamous cell carcinoma (ESCC). Methods: Patients diagnosed with resectable advanced ESCC at our hospital between January 2010 and December 2019 underwent either neoadjuvant DCF therapy or DCS therapy, followed by radical esophagectomy. Prior...
Nobufumi Sekino, Masayuki Kano, Sohei Kobayashi, Kentaro Murakami, Haruhito Sakata, Takeshi Toyozumi, Satoshi Endo, Yasunori Matsumoto, Hiroshi Suito, Masahiko Takahashi, Ryota Otsuka, Masaya Yokoyama, Tadashi Shiraishi, Koichiro Okada, Toshiki Kamata, Takahiro Ryuzaki, Soichiro Hirasawa, Kazuya Kinoshita, Takuma Sasaki, Keiko Iida, Aki Komatsu, Hisahiro Matsubara
Oncology (2022) 100 (5): 267–277.
Published Online: 08 February 2022
... Kinoshita; Takuma Sasaki; Keiko Iida; Aki Komatsu; Hisahiro Matsubara Introduction: Antidiabetic drug metformin exerts various antitumor effects on different cancers. Esophageal squamous cell carcinoma (ESCC) is an intractable digestive organ cancer and new treatment strategy is required. In this study, we...
Jhe-Cyuan Guo, Chen-Yuan Lin, Chia-Chi Lin, Ta-Chen Huang, Ming-Yu Lien, Li-Chun Lu, Hung-Yang Kuo, Chih-Hung Hsu
Oncology (2021) 99 (10): 652–658.
Published Online: 02 August 2021
... is associated with the response to ICIs in patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC). Methods: Patients with ESCC who had measurable tumors in the liver, lung, or lymph node (LN) according to the response evaluation criteria in solid tumors (RECIST) 1.1 and received ICIs...
Takaomi Hagi, Yukinori Kurokawa, Tsuyoshi Takahashi, Takuro Saito, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Makoto Yamasaki, Kiyokazu Nakajima, Masaki Mori, Yuichiro Doki
Oncology (2020) 98 (4): 222–229.
Published Online: 17 December 2019
... sensitive detection of circulating tumor DNA (ctDNA) in a relatively wide range of genes. Objective: The aim of this study was to examine the utility of NGS with MB for detecting ctDNA in patients with esophageal squamous cell carcinoma (ESCC). Methods: Five patients with ESCC who underwent preoperative...
Keijiro Sugimura, Hiroshi Miyata, Naoki Shinno, Hajime Ushigome, Kei Asukai, Yoshitomo Yanagimoto, Shinnichiro Hasegawa, Yusuke Takahashi, Daisaku Yamada, Kazuyoshi Yamamoto, Junichi Nishimura, Masaaki Motoori, Hiroshi Wada, Hidenori Takahashi, Masayoshi Yasui, Takeshi Omori, Masayuki Ohue, Masahiko Yano
Oncology (2019) 97 (6): 348–355.
Published Online: 28 August 2019
.... By investigating prognostic factors and recurrence patterns, we might be able to consider what kinds of additional treatment are necessary for patients who undergo DCF NAC followed by surgery. Medical records of patients with cStage I B-III (excluding T4) thoracic esophageal squamous cell carcinoma (ESCC...
Quoc Thang Pham, Naohide Oue, Yohei Sekino, Yuji Yamamoto, Yoshinori Shigematsu, Naoya Sakamoto, Kazuhiro Sentani, Naohiro Uraoka, Wataru Yasui
Oncology (2018) 95 (5): 297–308.
Published Online: 22 August 2018
...Quoc Thang Pham; Naohide Oue; Yohei Sekino; Yuji Yamamoto; Yoshinori Shigematsu; Naoya Sakamoto; Kazuhiro Sentani; Naohiro Uraoka; Wataru Yasui Objective: Esophageal cancer is one of the deadliest cancers in the world, and the main subtype is esophageal squamous cell carcinoma (ESCC), which...
Kazuki Sudo, Ken Kato, Hiroki Kuwabara, Yusuke Sasaki, Naoki Takahashi, Hirokazu Shoji, Satoru Iwasa, Yoshitaka Honma, Natsuko T. Okita, Atsuo Takashima, Tetsuya Hamaguchi, Yasuhide Yamada, Yoshinori Ito, Jun Itami, Takahiro Fukuda, Kensei Tobinai, Narikazu Boku
Oncology (2018) 94 (1): 47–54.
Published Online: 28 October 2017
... was to investigate the utility of surveillance after definitive chemoradiotherapy (dCRT) in patients with squamous cell carcinoma. Methods: Patients who underwent dCRT for stage II/III (excluding T4) esophageal squamous cell carcinoma were analyzed. First failures following complete response were classified...
Keishi Yamashita, Kei Hosoda, Hiromitsu Moriya, Chikatoshi Katada, Mitsuhiro Sugawara, Hiroaki Mieno, Shoko Komori, Natsuya Katada, Masahiko Watanabe
Oncology (2017) 92 (4): 221–228.
Published Online: 21 January 2017
...Keishi Yamashita; Kei Hosoda; Hiromitsu Moriya; Chikatoshi Katada; Mitsuhiro Sugawara; Hiroaki Mieno; Shoko Komori; Natsuya Katada; Masahiko Watanabe Background: Neoadjuvant chemotherapy (NAC) has become prevalent in esophageal squamous cell carcinoma (ESCC), but its long-term prognostic advantages...
Osamu Shiraishi, Makoto Yamasaki, Tomoki Makino, Masaaki Motoori, Hiroshi Miyata, Masayuki Shinkai, Yutaka Kimura, Motohiro Hirao, Kazumasa Fujitani, Shigeyuki Tamura, Kenji Kobayashi, Masahiko Yano, Yuichiro Doki, Takushi Yasuda
Oncology (2017) 92 (2): 101–108.
Published Online: 02 December 2016
... esophageal squamous cell carcinoma (ESCC) requires reassessment. We have conducted a trial aiming at the comparison between DCF and ACF concerning perioperative adverse events. Methods: Patients were randomly assigned to receive either DCF [docetaxel 70 mg/m 2 , cisplatin 70 mg/m 2 on day 1, and 5...
Yujiro Nakahara, Makoto Yamasaki, Genta Sawada, Yasuhiro Miyazaki, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Shuji Takiguchi, Koshi Mimori, Masaki Mori, Yuichiro Doki
Oncology (2016) 90 (6): 347–355.
Published Online: 16 April 2016
... glutamate dehydrogenase (GDH). The current study aimed to evaluate the clinical and biological significance of SIRT4 in esophageal squamous cell carcinoma (ESCC). Methods: The study comprised 172 patients with surgically resected ESCC in two independent cohorts. SIRT4 mRNA expression was analyzed in Cohort...
Tomoya Yokota, Nobutoshi Ando, Hiroyasu Igaki, Masayuki Shinoda, Ken Kato, Junki Mizusawa, Hiroshi Katayama, Kenichi Nakamura, Haruhiko Fukuda, Yuko Kitagawa
Oncology (2015) 89 (3): 143–151.
Published Online: 16 April 2015
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Esophageal squamous cell carcinoma...
Yuka Isozaki, Isamu Hoshino, Yasunori Akutsu, Naoyuki Hanari, Mikito Mori, Takanori Nishimori, Kentaro Murakami, Naoki Akanuma, Takeshi Toyozumi, Masahiko Takahashi, Hiroshi Suito, Nobuyoshi Takeshita, Tetsuro Maruyama, Akane Suzuki, Toshinori Nakayama, Hisahiro Matsubara
Oncology (2014) 87 (6): 351–363.
Published Online: 05 September 2014
... of this study was to identify alternative compounds to the tumor suppressor miR-375 using the connectivity map (CMAP) and to validate the antitumor effects of the identified drugs in esophageal squamous cell carcinoma (ESCC). Methods: Gene profiling of miR-375-treated TE2 and T.Tn cells was applied in order...
Kazuhiro Kaneko, Tomonori Yano, Keiko Minashi, Takashi Kojima, Miki Ito, Hironaga Satake, Yoko Yajima, Yusuke Yoda, Hiroaki Ikematsu, Yasuhiro Oono, Ryuichi Hayashi, Masakatsu Onozawa, Atsushi Ohtsu
Oncology (2012) 84 (1): 57–64.
Published Online: 30 October 2012
...Kazuhiro Kaneko; Tomonori Yano; Keiko Minashi; Takashi Kojima; Miki Ito; Hironaga Satake; Yoko Yajima; Yusuke Yoda; Hiroaki Ikematsu; Yasuhiro Oono; Ryuichi Hayashi; Masakatsu Onozawa; Atsushi Ohtsu Background: Esophageal squamous cell carcinoma (ESCC) is often synchronously accompanied...
Seung Tae Kim, Kyong Hwa Park, Sang Cheul Oh, Jae Hong Seo, Sang Won Shin, Jun Suk Kim, Yeul Hong Kim
Oncology (2011) 79 (5-6): 363–369.
Published Online: 24 March 2011
...Seung Tae Kim; Kyong Hwa Park; Sang Cheul Oh; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim Despite first-line therapy, most patients with advanced esophageal squamous cell carcinoma (ESCC) experience disease progression and may become eligible for second-line chemotherapy. Although...
Masahide Ikeguchi, Hiroaki Saito, Kuniyuki Katano, Shunichi Tsujitani, Michio Maeta, Nobuaki Kaibara
Oncology (1997) 54 (4): 311–317.
Published Online: 30 June 2009
... the proliferative activity of cancer cells by immunostaining with the Ki-67 monoclonal antibody in 95 cases of surgically resected esophageal squamous cell carcinoma and compared them with the extent of lymphocytic infiltration of the tumor (LI) in the same specimens. The mean Ki-67 score of 43 tumors with low...
Mariusz Adam Goscinski, Zhen He Suo, Jahn Marthin Nesland, Wen-Tien Chen, Malgorzata Zakrzewska, Junsheng Wang, Shanshen Zhang, Vivi Ann Flørenes, Karl-Erik Giercksky
Oncology (2008) 75 (1-2): 49–59.
Published Online: 12 September 2008
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Esophageal squamous cell carcinoma Seprase Dipeptidyl peptidase IV Urokinase-type...
Isamu Hoshino, Hisahiro Matsubara, Aki Komatsu, Yasunori Akutsu, Takanori Nishimori, Yasuo Yoneyama, Kentaro Murakami, Haruhito Sakata, Kazuyuki Matsushita, Yukimasa Miyazawa, Ryan Brooks, Minoru Yoshida, Takenori Ochiai
Oncology (2008) 75 (1-2): 113–119.
Published Online: 11 September 2008
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. p53 Genetherapy Leptomycin B Esophageal squamous cell carcinoma Esophageal cancer is one of the most aggressive malignancies with an overall 5-year survival rate of less than...
Makoto Kammori, Naotaka Izumiyama, Ken-ichi Nakamura, Rie Kurabayashi, Mitsuhiko Kashio, Junko Aida, Steven S.S. Poon, Michio Kaminishi
Oncology (2007) 71 (5-6): 430–436.
Published Online: 18 September 2007
... of squamous cell carcinoma of the esophagus using tissue quantitative fluorescence in situ hybridization (Q-FISH). We hypothesized that the very rapid cell proliferation observed in esophageal squamous cell carcinomas might accelerate the telomere shortening and chromosomal instability associated...
Oncology (2007) 71 (3-4): 221–228.
Published Online: 23 July 2007
..., the significance of type VII collagen expression in esophageal squamous cell carcinoma (ESCC) has been unknown to date. Therefore, we examined the expression of type VIIcollagen in ESCC, and confirmed the association between type VIIcollagen expression and clinicopathologic characteristics. Methods: We...
Takatsugu Kan, Seiji Yamasaki, Kan Kondo, Naoki Teratani, Atsushi Kawabe, Junichi Kaganoi, Stephen J. Meltzer, Masayuki Imamura, Yutaka Shimada
Oncology (2006) 70 (1): 25–33.
Published Online: 10 March 2006
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Representational difference analysis of cDNA Esophageal squamous cell carcinoma Human...